Royal Gold, Inc. Share Price Target ‘$151.58’, now 16.2% Upside Potential

DirectorsTalk Interviews

Royal Gold, Inc. which can be found using ticker (RGLD) have now 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $167.00 and $129.00 calculating the mean target share price we have $151.58. (at the time of writing). Now with the previous closing price of $130.45 this indicates there is a potential upside of 16.2%. The 50 day moving average now sits at $121.82 while the 200 day moving average is $114.77. The market capitalization for the company is 8.46B. The stock price is currently at: $128.68 USD

The potential market cap would be $9,828,629,528 based on the market consensus.

The company has a dividend yield of 0.55%. Other points of data to note are a P/E ratio of 38.07, revenue per share of $9.84 and a 7.44% return on assets.

Royal Gold, Inc. is a precious metals stream and royalty company. The Company is engaged in the acquisition and management of precious metal streams, royalties, and similar production-based interests. The Company operates through two segments: Acquisition and Management of Stream Interests, and Acquisition and Management of Royalty Interests. The Company owns royalty interests on approximately 32 production stage properties, 18 development stage properties and on approximately 123 exploration stage properties. It owns a portfolio of producing, development, evaluation, and exploration stage streams and royalties on properties located in gold regions. The Company’s principal properties include Andacollo, Cortez, Khoemacau Project, Mount Milligan, Penasquito and Pueblo Viejo.

Share on:

Latest Company News

India’s smart meter rollout builds a larger digital grid market

India’s smart meter rollout is moving into a larger execution phase, expanding demand across metering hardware, communications, software and digital grid services.

Verici Dx strengthens commercial case for kidney transplant risk test

Verici Dx has published analysis showing its PTRA kidney transplant risk test could generate more than $191 million in US healthcare savings over two years.

Serica holds firm on Pharos offer as rival bid gains ground

Serica Energy has declared its £145.7 million Pharos Energy offer final after a higher rival proposal gained the backing of the Pharos board.

Law Debenture: Why AI fears and a UK takeover wave are reshaping Laura Foll’s portfolio (video)

Law Debenture’s Laura Foll explains how the trust’s unusual structure has helped drive long-term outperformance.

GBG lowers FY27 revenue growth outlook amid Americas Identity attrition

GB Group now expects FY27 group revenue growth of 1–3% after higher-than-expected customer volume attrition in its Americas Identity business. Adjusted operating profit margin is expected to be approximately 21%.

    Search